Canadian scientists are examining the link between menopausal hormonal shifts and the higher prevalence of Alzheimer's in women. New research from Sunnybrook Research Institute and Toronto Metropolitan University suggests that blood-based markers in midlife may predict future cognitive decline.
The 62 per cent disparity in Canadian dementia cases
A significant gender gap exists in neurodegenerative health, with women making up an estimated 62 per cent of people living with dementia in Canada as of 2020, according to the Alzheimer Society of Canada. While some might attribute this to the fact that women generally live longer than men, experts argue that longevity alone cannot explain the gap.
Professor Jennifer Rabin of the Hurvitz Brain Sciences Program at Sunnybrook Research Institute notes that while all women experience menopause, not all develop Alzheimer's. This suggests that for a specific subset of women, the menopausal transition puts them on a distinct biological trajectory toward cognitive impairment. This trend highlights a critical need to understand why the female brain is more susceptible to these pathologies.
How blood inflammation in 80 women signals risk
Recent research published in the journal Nature Medicine suggests that the biological shifts of menopause are detectable in the blood long before dementia symptoms appear. Scientists at the Sunnybrook Research Institute analyzed blood samples from 80 women between the ages of 43 and 58, categorizing them into pre-, peri-, and postmenopausal groups.
The study found that postmenopausal women exhibited significantly higher levels of inflammation in their blood compared to those in earlier stages of the transition. As reported in the source, these molecular changes are believed to be linked to cognitive decline later in life, suggesting that the menopause transition is a vital window for developing preventative strategies to optimize brain aging.
Validating findings across 2,814 women in the UK Biobank
To ensure the results were not an anomaly of a small sample size, the Sunnybrook researchers cross-referenced their data with the UK Biobank. This larger dataset included 2,814 women, age-matched between 45 and 60, to compare pre-to-perimenopausal and postmenopausal periods.
The analysis confirmed that the same shifts in blood molecules observed in the initial group of 80 women were present in the larger UK cohort. this validation strengthens the claim that these hormonal and inflammatory changes are a widespread biological phenomenon rather than an isolated occurrence, providing a more robust foundation for future clinical interventions.
What Natasha Rajah's brain-imaging study reveals about midlife memory
Parallel to the blood research,Professor Natasha Rajah at Toronto Metropolitan University (TMU) is conducting Canada's only brain-imaging study focused on how biological sex and menopause affect memory-related brain function. Her work through TMU's Brain Health Equity in Aging and Memory Lab has already documented a link between poor vascular health and memory decline during the postmenopausal period.
However, significant gaps in knowledge remain. According to the report, clinical studies have historically failed to account for sex-based biological differences, leaving it unclear exactly how specific female life experiences influence the onset of Alzheimer's symptoms. Furthermore, while the research points to lifestyle changes and physical activity as potential mitigations, the precise medical interventions required to halt this trajectory remain unverified. Professor Rajah has emphasized the need for more women from diverse backgrounds to participate in these studies to ensure the findings apply across all demographics.
Comments 0